| 25th Jul 2023 7:00 am |
RNS |
Grant of Options |
| 19th Jul 2023 7:01 am |
RNS |
Faron to Hold BEXMAB Study Conference Call |
| 19th Jul 2023 7:00 am |
RNS |
BEXMAB study update |
| 30th Jun 2023 4:52 pm |
RNS |
Holding(s) in Company |
| 29th Jun 2023 7:00 am |
RNS |
Announcement of Placing |
| 12th Jun 2023 7:00 am |
RNS |
Exercise of options |
| 9th Jun 2023 8:00 am |
RNS |
New biomarker data from BEXMAB study at EHA2023 |
| 5th Jun 2023 7:00 am |
RNS |
Board Member to Assume Transactional Advisor Role |
| 24th Apr 2023 7:00 am |
RNS |
Bexmarilimab Efficacy and Safety in MATINS Trial |
| 19th Apr 2023 7:00 am |
RNS |
Bexmarilimab KOL Event |
| 18th Apr 2023 7:00 am |
RNS |
Poster Presentations at AACR 2023 |
| 17th Apr 2023 7:00 am |
RNS |
BEXMAB study update |
| 13th Apr 2023 4:30 pm |
RNS |
Faron at Canaccord Oncology Virtual Conference |
| 29th Mar 2023 7:00 am |
RNS |
Appointment of Chief Financial Officer |
| 24th Mar 2023 1:35 pm |
RNS |
Board Change |
| 24th Mar 2023 1:30 pm |
RNS |
Results of AGM |
| 22nd Mar 2023 7:00 am |
RNS |
Positive FDA Feedback to Progress Bexmarilimab |
| 3rd Mar 2023 9:00 am |
RNS |
Notice of Faron Pharmaceuticals Ltd’s AGM |
| 3rd Mar 2023 7:15 am |
RNS |
Faron´s Annual Report 2022 Published |
| 3rd Mar 2023 7:00 am |
RNS |
Financial Statement January 1 to December 31 2022 |
| 6th Feb 2023 6:00 pm |
RNS |
Update to Faron’s Financial Calendar for 2023 |
| 6th Feb 2023 7:00 am |
RNS |
Notice of 2022 Full-Year Results and Annual Report |
| 1st Feb 2023 3:45 pm |
RNS |
Holding(s) in Company |
| 27th Jan 2023 5:45 pm |
RNS |
Holding(s) in Company |
| 27th Jan 2023 7:00 am |
RNS |
Results of Placing |
| 26th Jan 2023 4:30 pm |
RNS |
Proposed Issue and Placing |
| 16th Jan 2023 11:00 am |
RNS |
Price Monitoring Extension |
| 16th Jan 2023 9:05 am |
RNS |
Second Price Monitoring Extn |
| 16th Jan 2023 9:00 am |
RNS |
Price Monitoring Extension |
| 16th Jan 2023 7:00 am |
RNS |
Title: BEXMAB study update |
| 23rd Dec 2022 7:00 am |
RNS |
Faron’s Financial Calendar for 2023 |
| 5th Dec 2022 7:00 am |
RNS |
BEXMAB Study Update |
| 1st Dec 2022 7:00 am |
RNS |
Faron Appoints Maija Hollmén PhD as CSO |
| 18th Nov 2022 4:30 pm |
RNS |
Amendment Terms and Conditions with IPF Partners |
| 2nd Nov 2022 7:00 am |
RNS |
Faron Announces Poster Presentation at SITC |
| 31st Oct 2022 7:00 am |
RNS |
BEXMAB Study Update |
| 19th Oct 2022 9:20 am |
RNS |
Holding(s) in Company |
| 18th Oct 2022 12:30 pm |
RNS |
Holding(s) in Company |
| 18th Oct 2022 7:00 am |
RNS |
Faron Announces Melanoma Cohort Data from MATINS |
| 14th Oct 2022 7:00 am |
RNS |
Results of Placing |
